Opioid use disorder: current trends and potential treatments.  Lee YK, Gold MS, Blum K, Thanos PK, Hanna C, Fuehrlein BS.  Front Public Health. 2024 Jan 25;11:1274719. doi: 10.3389/fpubh.2023.1274719. PMID: 38332941; PMCID: PMC10850316...

USA. NIH/NIDA: Division of Therapeutics and Medical Consequences (DTMC) - DTMC Pipelines of Therapeutics - Opioid Use Disorder and Overdose aufgerufen am 04.02.2024 https://nida.nih.gov/about-nida/organization/divisions/division-t...

New strategies for medications to treat substance use disorders.  Montoya ID, Volkow ND.  Pharmacol Res. 2024 Jan 20;200:107078. doi: 10.1016/j.phrs.2024.107078. Epub ahead of print. PMID: 38246477. https://www.sciencedirect.com/scien...

Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022.  Bharat C, Chidwick K, Gisev N, Farrell M, Ali R, Degenhardt L.  Int J Drug Policy. 2024 Jan;123:104255. doi: 10.1016/j.drugpo.2023.104255. Epub 2023 Nov ...

Structural Basis of μ-Opioid Receptor-Targeting by a Nanobody Antagonist.  Yu J, Kumar A, Zhang X, Martin C, Raia P, Koehl A, Laeremans T, Steyaert J, Manglik A, Ballet S, Boland A, Stoeber M.  bioRxiv [Preprint]. 2023 Dec 7:2023....

Long-term detoxification of opioid use disorder with opium tincture assisted treatment.  Omidvar Tehrani S, Rezaei Ardani A, Akhlaghi S, Shayesteh Zarrin M, Talaei A.  Front Psychiatry. 2023 Dec 7;14:1273587. doi: 10.3389/fpsyt.2023.12...